Dry powders for oral inhalation free of lactose carrier particles
Open Access
- 1 August 2014
- journal article
- review article
- Published by Elsevier in Advanced Drug Delivery Reviews
- Vol. 75, 32-52
Abstract
No abstract availableKeywords
Funding Information
- Science Foundation Ireland (12/RC/2275, 12/IP/1408)
This publication has 148 references indexed in Scilit:
- Preparation and Characterization of Novel Magnetic Nano-in-Microparticles for Site-Specific Pulmonary Drug DeliveryMolecular Pharmaceutics, 2013
- Inhalation of a Dry Powder Ciprofloxacin Formulation in Healthy Subjects: A Phase I StudyClinical Drug Investigation, 2013
- Synthesis, Optimization, and Characterization of Camptothecin-Loaded Acetalated Dextran Porous Microparticles for Pulmonary DeliveryMolecular Pharmaceutics, 2012
- Influence of PEI as a core modifying agent on PLGA microspheres of PGE1, a pulmonary selective vasodilatorInternational Journal of Pharmaceutics, 2011
- Engineering gas-foamed large porous particles for efficient local delivery of macromolecules to the lungEuropean Journal of Pharmaceutical Sciences, 2010
- Formulation strategy and use of excipients in pulmonary drug deliveryInternational Journal of Pharmaceutics, 2010
- Inhalable large porous microspheres of low molecular weight heparin: In vitro and in vivo evaluationJournal of Controlled Release, 2008
- Prandial insulin: is inhaled enough?Drug Development Research, 2008
- A Delineation of Diketopiperazine Self-Assembly Processes: Understanding the Molecular Events Involved in Nϵ-(Fumaroyl)diketopiperazine of l-Lys (FDKP) InteractionsMolecular Pharmaceutics, 2008
- Pharmaceutical Particle Engineering via Spray DryingPharmaceutical Research, 2007